The Complexities and Challenges of Managing Genetic Causes of Hyperphosphataemia, a Case Report [PDF]
J Paediatr Child HealthJournal of Paediatrics and Child Health, Volume 61, Issue 8, Page 1332-1337, August 2025.
Farrah Rodrigues +3 more
wiley +2 more sources
Whitish Deposits in the Stomach and Duodenum [PDF]
United European Gastroenterol JUnited European Gastroenterology Journal, Volume 13, Issue 10, Page 1913-1915, December 2025.
Kai‐yan Yang, Xu‐jie Zhou, Wei Xie
wiley +2 more sources
Efficacy and safety of sucroferric oxyhydroxide versus sevelamer carbonate: A systematic review and meta‐analysis [PDF]
Hemodialysis International, Volume 29, Issue 1, Page 6-16, January 2025.Abstract Introduction Phosphate binders are commonly used in patients receiving kidney replacement therapy (KRT), aiming to reduce and maintain serum phosphorus. Chronic kidney disease‐mineral and bone disorder has been linked to reduced lifespan and worsened quality of life.
Christos Georgopoulos +5 more
wiley +2 more sources
A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients [PDF]
Kidney International ReportsIntroduction: Hyperphosphatemia in patients undergoing dialysis is not well-controlled. AP306 is a pan-inhibitor of phosphate transporters, designed to block the active uptake of phosphate through the gastrointestinal tract.
Li Wang +14 more
doaj +3 more sources
Evaluation of a Phosphate Management Protocol to Achieve Optimum Serum Phosphate Levels in Hemodialysis Patients [PDF]
, 2008 Original article can be found at: http://www.sciencedirect.com/science/journal/10512276 Copyright National Kidney Foundation, Inc. DOI: 10.1053/j.jrn.2008.05.003To evaluate the effectiveness of a protocol designed to optimize serum phosphate levels in ...
Cheung, C.F. +5 more
core +1 more source
Benefits of Sevelamer on Markers of Bone Turnover in Taiwanese Hemodialysis Patients
Journal of the Formosan Medical Association, 2010 Sevelamer hydrochloride is a recently developed phosphate binder, which is a quaternary amine anion exchanger without calcium or aluminum. Sevelamer is effective in controlling hyperphosphatemia without increasing the calcium load in chronic hemodialysis
Yu-Feng Lin +13 more
doaj +1 more source
Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies [PDF]
, 2018 Hyperphosphatemic familial tumoral calcinosis (HFTC)/hyperostosis-hyperphosphatemia syndrome (HHS) is an autosomal recessive disorder of ectopic calcification due to deficiency of or resistance to intact fibroblast growth factor 23 (iFGF23). Inactivating
Burbelo +14 more
core +1 more source
The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy [PDF]
Journal of Nephropathology, 2018 Background: Diabetic nephropathy (DN) is one of the major complications of diabetes. Hyperglycemia, inflammation and oxidative stress as well as advanced glycation end products (AGEs) are reported as the risk factors for DN. Sevelamer has shown promising
Sosan Mohammadi Kebar +5 more
doaj +1 more source
Sevelamer Carbonate Crystal-Induced Colitis
Case Reports in Gastrointestinal Medicine, 2020 Hyperphosphatemia is a common and well-described complication of end-stage renal disease. Despite strict dietary constraints and compliance, phosphate binders such as calcium acetate and/or sevelamer carbonate are also needed to treat secondary ...
T. Lai +3 more
doaj +1 more source
Frontiers in Medicine, 2023 Chronic kidney disease (CKD) is a very common chronic non-communicable disease. Phosphate and calcium metabolism disorders are one of the most common features of CKD.
Margareta Fistrek Prlic +13 more
doaj +1 more source